SCHEMBL28502698

SCHEMBL28502698

Brc1cc(C2CC2)c2[nH]ncc2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 4/20 0.45
▸ IDO1 P14902 3/20 0.45
▸ NOS1 P29475 4/20 0.41
▸ METAP2 P50579 2/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ DYRK1A Q13627 2/20 0.37
▸ TRPA1 O75762 1/20 0.35
▸ JAK2 O60674 2/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ MASP2 O00187 1/20 0.32
▸ F2 P00734 1/20 0.32
▸ ROCK2 O75116 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29209798 0.81 TRPA1 (0.39) TDO2IDO1NOS1METAP2TRPA1
SCHEMBL29209720 0.79 TDO2 (0.45) TDO2IDO1NOS1DYRK1ATRPA1
SCHEMBL11577531 0.74 NOS1 (0.53) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL25115550 0.72 TDO2 (0.42) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL31358022 0.71 NOS1 (0.52) IDO1NOS1TRPA1KDM4EMEN1
SCHEMBL758690 0.71 NOS1 (0.46) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL31472072 0.71 NOS1 (0.46) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL3601695 0.71 NOS1 (0.50) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL766959 0.71 NOS1 (0.46) TDO2IDO1NOS1METAP2CSNK2A1
SCHEMBL1145088 0.71 NOS1 (0.46) TDO2IDO1NOS1METAP2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108467386-B Fused heteroaryl substituted 1,2, 4-triazine-3-amine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2020-11-17 — — CN disclosed
Send feedback